Stay updated on FALCON: Bardoxolone in ADPKD Clinical Trial
Sign up to get notified when there's something new on the FALCON: Bardoxolone in ADPKD Clinical Trial page.

Latest updates to the FALCON: Bardoxolone in ADPKD Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check13 days agoChange DetectedThe page has removed references to Reata as a subsidiary of Biogen and updated the revision number from v2.16.1 to v2.16.2. Additionally, a date has been changed from June 11, 2024, to June 3, 2025.SummaryDifference3%
- Check20 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference5%
- Check27 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check63 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
Stay in the know with updates to FALCON: Bardoxolone in ADPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FALCON: Bardoxolone in ADPKD Clinical Trial page.